Update on quetiapine supply tensions: long-term mobilization to best meet patients’ needs

News Healthcare & Pharma Reports

Date: 24th Apr, 2025 Source: French National Agency for the Safety of Medicines and Health Products (ANSM) Country: France Original Source

Brief

On July 2024, the French National Agency for the Safety of Medicines and Health Products (ANSM) mobilized to address a complex situation related to a risk of quetiapine shortage. The agency has been actively working with laboratories and healthcare professionals to cover patient needs, including recalling stock, activating solidarity mechanisms, and identifying alternative treatments, resulting in the distribution of nearly 30,000 equivalent monthly treatments.

This content is restricted.

Highlights content goes here...

This content is restricted.

French National Agency for the Safety of Medicines and Health Products (ANSM)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Update on quetiapine supply tensions: long-term mobilization to best meet patients’ needs

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Update on quetiapine supply tensions: long-term mobilization to best meet patients’ needs

Brief

French National Agency for the Safety of Medicines and Health Products (ANSM)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.